n this study, we followed the genomic, lipidomic and metabolomic changes associated with the selection of miltefosine (MIL) resistance in two clinically derived Leishmania donovani strains with different inherent resistance to antimonial drugs (antimony sensitive strain Sb-S; and antimony resistant Sb-R). MIL-R was easily induced in both strains using the promastigote-stage, but a significant increase in MIL-R in the intracellular amastigote compared to the corresponding wild-type did not occur until promastigotes had adapted to 12.2 μM MIL. A variety of common and strain-specific genetic changes were discovered in MIL-adapted parasites, including deletions at the LdMT transporter gene, single-base mutations and changes in somy. The most ob...
Leishmania donovani is an intracellular protozoan parasite that causes visceral leishmaniasis (VL). ...
AbstractThere are many theories as to the mode of action of miltefosine against Leishmania including...
20 p.-3 fig.-4 tab.Leishmania infantum is an etiological agent of the life-threatening visceral form...
In this study, we followed the genomic, lipidomic and metabolomic changes associated with the select...
In this study, we followed the genomic, lipidomic and metabolomic changes associated with the select...
In this study, we followed the genomic, lipidomic and metabolomic changes associated with the select...
n this study, we followed the genomic, lipidomic and metabolomic changes associated with the selecti...
In this study we followed the genomic, lipidomic and metabolomic changes associated with the selecti...
In this study, we followed the genomic, lipidomic and metabolomic changes associated with the select...
Understanding the mechanism(s) underpinning drug resistance could lead to novel treatments to revers...
Visceral leishmaniasis (VL) is estimated to cause over 300,000 deaths annually, with over 90% of the...
Abstract Visceral leishmaniasis is a devastating neglected parasitic disease caused by infection wit...
Miltefosine (hexadecylphosphocholine) is the first oral antileishmanial drug. In this study, we addr...
International audienceDuring the last decade miltefosine (MIL) has been used as first-line treatment...
Leishmaniasis is a serious medical issue in many countries around the World, but it remains largely ...
Leishmania donovani is an intracellular protozoan parasite that causes visceral leishmaniasis (VL). ...
AbstractThere are many theories as to the mode of action of miltefosine against Leishmania including...
20 p.-3 fig.-4 tab.Leishmania infantum is an etiological agent of the life-threatening visceral form...
In this study, we followed the genomic, lipidomic and metabolomic changes associated with the select...
In this study, we followed the genomic, lipidomic and metabolomic changes associated with the select...
In this study, we followed the genomic, lipidomic and metabolomic changes associated with the select...
n this study, we followed the genomic, lipidomic and metabolomic changes associated with the selecti...
In this study we followed the genomic, lipidomic and metabolomic changes associated with the selecti...
In this study, we followed the genomic, lipidomic and metabolomic changes associated with the select...
Understanding the mechanism(s) underpinning drug resistance could lead to novel treatments to revers...
Visceral leishmaniasis (VL) is estimated to cause over 300,000 deaths annually, with over 90% of the...
Abstract Visceral leishmaniasis is a devastating neglected parasitic disease caused by infection wit...
Miltefosine (hexadecylphosphocholine) is the first oral antileishmanial drug. In this study, we addr...
International audienceDuring the last decade miltefosine (MIL) has been used as first-line treatment...
Leishmaniasis is a serious medical issue in many countries around the World, but it remains largely ...
Leishmania donovani is an intracellular protozoan parasite that causes visceral leishmaniasis (VL). ...
AbstractThere are many theories as to the mode of action of miltefosine against Leishmania including...
20 p.-3 fig.-4 tab.Leishmania infantum is an etiological agent of the life-threatening visceral form...